Etelcalcetide OverviewEtelcalcetide (formerly velcalcetide, trade name Parsabiv) is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. It is administered intravenously at the end of each dialysis session. Etelcalcetide functions by binding to and activating the calcium-sensing receptor in the parathyroid gland. Parsabiv is currently owned by Amgen and Ono Pharmaceuticals in Japan.&am...
Read more Etelcalcetide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Etelcalcetide
Recent Etelcalcetide Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 10mg/2ml, 2.5mg/0.5ml, 5mg/ml
- Solution: 10mg/2ml (5mg/ml), 2.5mg/0.5ml (2.5mg/0.5ml), 5mg/ml (5mg/ml)
Other drugs which contain Etelcalcetide or a similar ingredient: (1 result)
- PARSABIV Etelcalcetide